# Cardior Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardior-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Hannover, Germany
- Website: www.cardior.de/
- Total disclosed funding: $91M
- Latest round: Series B (Aug 26, 2021)
- Investors on record: 10

## About

Based in Hannover, Germany, and founded in 2016 by co-founders Claudia Ulbrich MD, Thomas Thum MD, and Sandor Batkai, Cardior Pharmaceuticals GmbH operates as a provider of RNA-based therapies to halt and reverse cardiac remodeling post-myocardial infarction, targeting heart disease patients. In March 2024, Novo Nordisk A/S, a portfolio company of Flagship Pioneering, agreed to acquire Cardior Pharmaceuticals GmbH from BioMed Partners, Boehringer Ingelheim Venture, Bristol-Myers Squibb Company, EQT Life Sciences, High-Tech Gründerfonds, European Regional Development Fund, Coparion, Fund+, Hadean Ventures, Inkef, and Sunstone Life Science Ventures for approximately EUR 1.025 billion, including an upfront payment.

The company provides a wide range of therapeutic solutions, such as non-coding RNA-based therapies to reverse adverse cardiac remodeling and improve heart function. Additionally, the firm also provides clinical trial services to evaluate treatment efficacy and safety.

## Funding rounds

- Series B, Aug 26, 2021, $75M — BioMed Partners, Bristol-Myers Squibb Company, High-Tech Gruenderfonds, Inkef, Hadean Ventures, Fund+, Coparion, Sunstone Life Science Ventures
- Series A, May 5, 2017, $16M — EQT Life Sciences, BioMed Partners, Boehringer Ingelheim Venture, Bristol-Myers Squibb Company, High-Tech Gruenderfonds

## Investors

- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series A
- BioMed Partners (https://capitalatlas.ai/funds/biomed-partners) — Series A, Series B
- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Series A
- Bristol-Myers Squibb Company — Series A, Series B
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Series A, Series B
- Inkef (https://capitalatlas.ai/funds/inkef) — Series B
- Hadean Ventures (https://capitalatlas.ai/funds/hadean-ventures) — Series B
- Fund+ (https://capitalatlas.ai/funds/fund) — Series B
- Coparion (https://capitalatlas.ai/funds/coparion) — Series B
- Sunstone Life Science Ventures (https://capitalatlas.ai/funds/sunstone-life-science-ventures) — Series B